XML 51 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Investment in Investees
3 Months Ended
Mar. 31, 2013
Investment in Investees [Abstract]  
Investment in Investee
INVESTMENT IN INVESTEE
Investment in investee includes the Company's investment in the preferred and restricted voting common stock of Atlas Financial Holdings Inc. ("Atlas").  The Company accounted for this investment as of and for the three months ended March 31, 2013 under the equity method because the Company was deemed to have significant influence over Atlas during this period.  The Company's investment in Atlas is recorded on a three-month lag basis.  The carrying value, estimated fair value and approximate voting and equity percentages at March 31, 2013 and December 31, 2012 were as follows:
(in thousands, except for percentages)
 
 
 
 
 
 
 
 
 
 
 
March 31, 2013
 
December 31, 2012
 
Voting percentage
 
Equity percentage
 
Estimated Fair Value
 
Carrying value
 
Voting percentage
 
Equity percentage
 
Estimated Fair Value
 
Carrying value
Atlas
16.5
%
 
16.5
%
 
$
25,994

 
$
26,526

 
30.0
%
 
63.3
%
 
$
38,758

 
$
41,733



The fair values of the Company's investment in Atlas at March 31, 2013 and December 31, 2012 in the table above are calculated based on the published closing prices of Atlas at December 31, 2012 and September 30, 2012, respectively, to be consistent with the three-month lag in reporting its carrying value under the equity method. The estimated fair value of the Company's investment in Atlas based on the published closing price of Atlas at March 31, 2013 is $25.5 million.
Equity in net income (loss) of investee was income of $0.3 million and a loss of $2.3 million for the three months ended March 31, 2013 and March 31, 2012, respectively. The Company also recognized a decrease to shareholders' equity attributable to common shareholders of $0.1 million for the three months ended March 31, 2013 for the Company's pro rata share of its investee's accumulated other comprehensive income.
Summarized financial information for Atlas is presented below at December 31, 2012. To be consistent with the three-month lag in reporting, total revenue and net income is presented below for the three months ended December 31, 2012:
(in thousands)
 
Three months ended December 31, 2012

Total revenue
 
12,851

Net income
 
1,244



On February 12, 2013, the Company executed an underwriting agreement to sell 2,625,000 shares of Atlas common stock. The shares were being offered as part of Atlas' United States initial public offering at a price per share of $5.85. The Company received net proceeds of $13.6 million and recognized a loss of $1.7 million which is included in net realized losses on the consolidated statements of operations, resulting from commissions and other expenses incurred as part of the sale, during the first quarter.